Source:http://linkedlifedata.com/resource/pubmed/id/17016438
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
16
|
pubmed:dateCreated |
2007-4-5
|
pubmed:abstractText |
We have previously reported that insulin-like growth factor-I (IGF-I) supports growth and survival of mouse and human medulloblastoma cell lines, and that IGF-I receptor (IGF-IR) is constitutively phosphorylated in human medulloblastoma clinical samples. Here, we demonstrate that a specific inhibitor of insulin-like growth factor-I receptor (IGF-IR), NVP-AEW541, attenuated growth and survival of mouse (BsB8) and human (D384, Daoy) medulloblastoma cell lines. Cell cycle analysis demonstrated that G1 arrest and apoptosis contributed to the action of NVP-AEW54. Interestingly, very aggressive BsB8 cells, which derive from cerebellar tumors of transgenic mice expressing viral oncoprotein (large T-antigen from human polyomavirus JC) became much more sensitive to NVP-AEW541 when exposed to anchorage-independent culture conditions. This high sensitivity to NVP-AEW54 in suspension was accompanied by the loss of GSK-3beta constitutive phosphorylation and was independent from T-antigen-mediated cellular events (Supplementary Materials). BsB8 cells were partially rescued from NVP-AEW541 by GSK3beta inhibitor, lithium chloride and were sensitized by GSK3beta activator, sodium nitroprusside (SNP). Importantly, human medulloblastoma cells, D384, which demonstrated partial resistance to NVP-AEW541 in suspension cultures, become much more sensitive following SNP-mediated GSK3beta dephosphorylation (activation). Our results indicate that hypersensitivity of medulloblastoma cells in anchorage-independence is linked to GSK-3beta activity and suggest that pharmacological intervention against IGF-IR with simultaneous activation of GSK3beta could be highly effective against medulloblastomas, which have intrinsic ability of disseminating the CNS via cerebrospinal fluid.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0950-9232
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
5
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2308-17
|
pubmed:dateRevised |
2011-11-2
|
pubmed:meshHeading |
pubmed-meshheading:17016438-Animals,
pubmed-meshheading:17016438-Cell Division,
pubmed-meshheading:17016438-Cell Line, Tumor,
pubmed-meshheading:17016438-Cell Survival,
pubmed-meshheading:17016438-Cerebellar Neoplasms,
pubmed-meshheading:17016438-Glycogen Synthase Kinase 3,
pubmed-meshheading:17016438-Humans,
pubmed-meshheading:17016438-Male,
pubmed-meshheading:17016438-Medulloblastoma,
pubmed-meshheading:17016438-Mice,
pubmed-meshheading:17016438-Mice, Transgenic,
pubmed-meshheading:17016438-Phosphorylation,
pubmed-meshheading:17016438-Receptor, IGF Type 1
|
pubmed:year |
2007
|
pubmed:articleTitle |
Inhibition of IGF-I receptor in anchorage-independence attenuates GSK-3beta constitutive phosphorylation and compromises growth and survival of medulloblastoma cell lines.
|
pubmed:affiliation |
Department of Neuroscience, Center for Neurovirology, Temple University, Philadelphia, PA 19122, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|